BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2900897)

  • 1. Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists.
    King FD; Hadley MS; McClelland CM
    J Med Chem; 1988 Sep; 31(9):1708-12. PubMed ID: 2900897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted benzamides with conformationally restricted side chains. 1. Quinolizidine derivatives as selective gastric prokinetic agents.
    Hadley MS; King FD; McRitchie B; Turner DH; Watts EA
    J Med Chem; 1985 Dec; 28(12):1843-7. PubMed ID: 4068007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
    J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides.
    Kato S; Morie T; Hino K; Kon T; Naruto S; Yoshida N; Karasawa T; Matsumoto J
    J Med Chem; 1990 May; 33(5):1406-13. PubMed ID: 2139471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities.
    Florvall L; Ogren SO
    J Med Chem; 1982 Nov; 25(11):1280-6. PubMed ID: 6128419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility.
    Alphin RS; Proakis AG; Leonard CA; Smith WL; Dannenburg WN; Kinnier WJ; Johnson DN; Sancilio LF; Ward JW
    Dig Dis Sci; 1986 May; 31(5):524-9. PubMed ID: 3698769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on central dopaminergic receptors (D-2) using the antagonistic properties of new benzamides.
    Rumigny JF; Strolin Benedetti M; Dostert P
    J Pharm Pharmacol; 1984 Jun; 36(6):373-7. PubMed ID: 6146667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
    Ohmori J; Maeno K; Hidaka K; Nakato K; Matsumoto M; Tada S; Hattori H; Sakamoto S; Tsukamoto S; Usuda S; Mase T
    J Med Chem; 1996 Jul; 39(14):2764-72. PubMed ID: 8709107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptors.
    Bishop JE; Mathis CA; Gerdes JM; Whitney JM; Eaton AM; Mailman RB
    J Med Chem; 1991 May; 34(5):1612-24. PubMed ID: 1827843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
    Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 1.
    van Wijngaarden I; Kruse CG; van Hes R; van der Heyden JA; Tulp MT
    J Med Chem; 1987 Nov; 30(11):2099-104. PubMed ID: 2889830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
    Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
    Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidopaminergic effects of the stereoisomers of N-[(1-alkyl-2- pyrrolidinyl)methyl]-5-sulfamoylbenzamides and -2,3-dihydrobenzofuran-7-carboxamides.
    Murakami S; Marubayashi N; Fukuda T; Takehara S; Tahara T
    J Med Chem; 1991 Jan; 34(1):261-7. PubMed ID: 1825115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
    Megens AA; Awouters FH; Niemegeers CJ
    Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties.
    Yoshida N; Omoya H; Oka M; Furukawa K; Ito T; Karasawa T
    Arch Int Pharmacodyn Ther; 1989; 300():51-67. PubMed ID: 2533479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anilides related to substituted benzamides. Potential antipsychotic activity of N-(4-amino-5-chloro-2-methoxyphenyl)-1-(phenylmethyl)-4-piperidinecarboxamide.
    Blaney FE; Clark MS; Gardner DV; Hadley MS; Middleton D; White TJ
    J Med Chem; 1983 Dec; 26(12):1747-52. PubMed ID: 6644744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 20. Optically active benzamides as predictive tools for mapping the dopamine D2 receptor.
    Rognan D; Sokoloff P; Mann A; Martres MP; Schwartz JC; Costentin J; Wermuth CG
    Eur J Pharmacol; 1990 Jul; 189(1):59-70. PubMed ID: 1977603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.